EUVIMEDEUVIMED entdecken
Vergleichsstudie

The Safety and Efficacy of Secondary Spontaneous Pneumothorax Surgery: Especially in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease

Taishi Adachi, Mitsugu Omasa, Ren Takehara, Takao Nakanishi, Hideki Motoyama

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf410 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Taishi Adachi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Hyōgo 651 2273, Japan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Pneumothorax, Postoperative Complications. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To clarify the surgical indications for secondary spontaneous pneumothorax (SSP), we compared the outcomes between interstitial lung disease (ILD)- and chronic obstructive pulmonary disease (COPD)-associated SSP using propensity score matching (PSM) and identified the risk factors for recurrence, prolonged air leakage (PAL), and postoperative complications.

Methods

We retrospectively analysed 138 patients who underwent SSP surgery for the first time. Outcomes were 3-year overall survival (OS), recurrence-free survival (RFS), and short-term outcomes (PAL ≥2 days; postoperative complications [Clavien-Dindo grade ≥3] and mortality). After 1:1 PSM, we compared ILD with COPD and explored group-specific risk factors.

Results

The median postoperative air leak duration was 0 days (range: 0-13). Complications occurred in 3.6%, and mortality in 2.2% of cases. Three-year OS and RFS were 85.3% and 77.7%, respectively. ILD was a risk factor for recurrence (hazard ratio [HR] 6.29, 95% confidence interval [CI] 2.29-17.33; P < .001). After PSM (25 pairs), ILD showed worse RFS (P = .001) and OS (P = .010), while short-term outcomes were comparable. In ILD, interstitial abnormalities involving >1 lobe were a risk factor for recurrence (HR 13.74, 95% CI 2.78-67.95; P = .001), and combined pulmonary fibrosis and emphysema (CPFE) was a risk factor for PAL (odds ratio [OR] 7.94, 95% CI 1.32-47.62; P = .023). In COPD, ipsilateral pneumothorax history was a risk factor for recurrence (HR 15.50, 95% CI 1.81-133.20; P = .012).

Conclusions

SSP appears safe for selected patients. Despite worse long-term outcomes in ILD, comparable short-term results support surgery when benefits are expected; caution is warranted in patients with interstitial abnormalities in >1 lobe, CPFE, or steroid therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialPulmonary Disease, Chronic ObstructivePneumothoraxPostoperative ComplicationsLungRetrospective StudiesPropensity ScoreRisk FactorsProportional Hazards ModelsRecurrenceTreatment OutcomeHumansMaleFemaleAdultMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

COPDILDpropensity score matchingsecondary spontaneous pneumothoraxsurgery

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Hyōgo 651 2273, Japan.

Zitieren

APA

Adachi, T., Omasa, M., Takehara, R., Nakanishi, T., & Motoyama, H. (2025). The Safety and Efficacy of Secondary Spontaneous Pneumothorax Surgery: Especially in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf410

Vancouver

Adachi T, Omasa M, Takehara R, Nakanishi T, Motoyama H. The Safety and Efficacy of Secondary Spontaneous Pneumothorax Surgery: Especially in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf410

BibTeX
@article{Adachi2025,
  author = {Adachi, Taishi and Omasa, Mitsugu and Takehara, Ren and Nakanishi, Takao and Motoyama, Hideki},
  title = {The Safety and Efficacy of Secondary Spontaneous Pneumothorax Surgery: Especially in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf410}
}
Kostenlos starten →